We Need to Talk About CRISPR
By Staff,
The Medicine Maker
| 03. 21. 2025
"The Promise and Peril of CRISPR" cover by Johns Hopkins University Press
As a paediatrician taking care of children with sickle cell disease, Neal Baer, a Harvard Medical School graduate, was in awe of the power of CRISPR technologies. Later becoming a TV show writer (for hit shows such as ER, Law and Order, and Under the Dome), Baer realized that the promise of advanced medicine could quickly become a peril, if placed in the wrong hands. This inspired him to compile a collection of essays that asks how far could – or should – humanity develop it. The Promise and the Peril of CRISPR chronicles the human condition in the 21st century, and asks what is more valuable: saving lives, or wielding power? Here he discusses the duality of CRISPR.
What inspired you to compile a collection of essays about CRISPR specifically?
There are lots of reasons. It’s important to know who has access to the data, and the DNA. Is it safe? What are the unforeseen consequences? Will there still be problems once one piece of DNA...
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...